Sonoma Pharmaceuticals Statistics
Total Valuation
SNOA has a market cap or net worth of $3.52 million. The enterprise value is -$311,983.
Important Dates
The next estimated earnings date is Thursday, February 6, 2025, after market close.
| Earnings Date | Feb 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SNOA has 1.34 million shares outstanding. The number of shares has increased by 265.61% in one year.
| Current Share Class | 1.34M |
| Shares Outstanding | 1.34M |
| Shares Change (YoY) | +265.61% |
| Shares Change (QoQ) | +21.44% |
| Owned by Insiders (%) | 1.56% |
| Owned by Institutions (%) | 2.07% |
| Float | 1.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | 0.20 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.69 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.85% and return on invested capital (ROIC) is -45.32%.
| Return on Equity (ROE) | -66.85% |
| Return on Assets (ROA) | -19.56% |
| Return on Capital (ROIC) | -45.32% |
| Revenue Per Employee | $1.35M |
| Profits Per Employee | -$368,600 |
| Employee Count | 10 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 3.11 |
Taxes
| Income Tax | -56,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.05% in the last 52 weeks. The beta is 1.42, so SNOA's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -15.05% |
| 50-Day Moving Average | 2.82 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 316,603 |
Short Selling Information
The latest short interest is 40,411, so 3.02% of the outstanding shares have been sold short.
| Short Interest | 40,411 |
| Short Previous Month | 77,033 |
| Short % of Shares Out | 3.02% |
| Short % of Float | 3.07% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
In the last 12 months, SNOA had revenue of $13.55 million and -$3.69 million in losses. Loss per share was -$4.61.
| Revenue | 13.55M |
| Gross Profit | 5.22M |
| Operating Income | -4.28M |
| Pretax Income | -4.58M |
| Net Income | -3.69M |
| EBITDA | -4.12M |
| EBIT | -4.28M |
| Loss Per Share | -$4.61 |
Full Income StatementBalance Sheet
The company has $4.08 million in cash and $244,000 in debt, giving a net cash position of $3.83 million or $2.86 per share.
| Cash & Cash Equivalents | 4.08M |
| Total Debt | 244,000 |
| Net Cash | 3.83M |
| Net Cash Per Share | $2.86 |
| Equity (Book Value) | 5.35M |
| Book Value Per Share | 4.00 |
| Working Capital | 8.91M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.51 million and capital expenditures -$29,000, giving a free cash flow of -$1.54 million.
| Operating Cash Flow | -1.51M |
| Capital Expenditures | -29,000 |
| Free Cash Flow | -1.54M |
| FCF Per Share | -$1.15 |
Full Cash Flow StatementMargins
Gross margin is 38.52%, with operating and profit margins of -31.56% and -27.21%.
| Gross Margin | 38.52% |
| Operating Margin | -31.56% |
| Pretax Margin | -27.62% |
| Profit Margin | -27.21% |
| EBITDA Margin | -30.38% |
| EBIT Margin | -31.56% |
| FCF Margin | n/a |